Current management of hepatocellular carcinoma

Table 9 Existing series on treatment of hepatocellular cancer: stereotactic body radiation therapy and radioembolization with yttrium-90

Treatment	Ref.	Year	Number	Overall survival
Radiotherapy	Kwon et al[145]	2010	42	58.6% (3 yr)
	Andolino et al[146]	2011	60	67% (2 yr)
	Huang et al[147]	2012	36	64% (2 yr)
	Kang et al[148]	2012	47	68.7% (2 yr)
	Facciuto et al[149]	2012	117	1Median 32 mo
Radioembolization	Carr et al[28]	2004	65	Median 21.3 mo
	Sangro et al[150]	2006	24	Median 7 mo
	Kulik et al[151]	2008	108	2Median 15.6 mo
				3Median 4.4 mo
	Hilgard et al[152]	2010	108	Median 16.4 mo
	Salem et al[153]	2010	291	4Median 7.7 mo
	Salem et al[29]	2011	123	Median 20.7 mo

¹Post liver transplant;

²No portal vein thrombosis;

³With main portal vein thrombosis;

⁴Child B cirrhosis.